![Doron Cohen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Doron Cohen
Finanzdirektor/CFO bei
GALMED PHARMACEUTICALS LTD.
Vermögen: 12 278 $ am 30.06.2026
Profil
Doron Cohen currently works at Galmed Pharmaceuticals Ltd., as Chief Financial Officer from 2022 and OnKai, Inc., as Chief Financial Officer from 2023.
Mr. Cohen also formerly worked at Tangram Strategic Ltd., as Chief Executive Officer, Gems Investment Research Ltd., as Research Director from 1992 to 2017, and World Union of Jewish Students, as Director-Public Relations from 1990 to 1992.
Mr. Cohen received his graduate degree from Boston University and undergraduate degree from The University of New South Wales.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.03.2026 | 22.083 ( 0,33 % ) | 12 278 $ | 30.06.2026 |
Aktive Positionen von Doron Cohen
| Unternehmen | Position | Beginn |
|---|---|---|
| GALMED PHARMACEUTICALS LTD. | Finanzdirektor/CFO | 01.02.2022 |
Onkai, Inc.
 Onkai, Inc. Packaged SoftwareTechnology Services Develops an AI-based platform that helps local health care professionals | Finanzdirektor/CFO | 01.10.2023 |
Ehemalige bekannte Positionen von Doron Cohen
| Unternehmen | Position | Ende |
|---|---|---|
Gems Investment Research Ltd. | Corporate Officer/Principal | 01.01.2017 |
Tangram Strategic Ltd. | Vorstandsvorsitzender | - |
Ausbildung von Doron Cohen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galmed Pharmaceuticals Ltd.
 Galmed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures aramchol for non-alcoholic steatohepatitis | Health Technology |
Gems Investment Research Ltd. | |
Onkai, Inc.
Onkai, Inc. Packaged SoftwareTechnology Services Develops an AI-based platform that helps local health care professionals | Technology Services |
Tangram Strategic Ltd. |
